Literature DB >> 21182981

Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.

Erlong Zhang1, Chao Zhang, Yongping Su, Tianmin Cheng, Chunmeng Shi.   

Abstract

The development of multifunctional agents that could be used for simultaneous tumor targeting, imaging and treatment is a major goal in cancer research and is expected to contribute significantly to the realization of personalized oncology. Mitochondria are involved in diverse physiological activities and confer vital roles in cancer development and progression. Increasing efforts are being made to develop cancer treatment strategies based on various mitochondrial targets and novel mitochondrial drug delivery systems. Multifunctional nanostructures or multifunctional chemical compounds further broaden the current concept of tumor targeting and provide alternative solutions for mitochondrially targeted cancer therapy.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182981     DOI: 10.1016/j.drudis.2010.12.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  25 in total

Review 1.  Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

Authors:  Thuy Trang Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  PEGylation and zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles.

Authors:  Jinbin Liu; Mengxiao Yu; Xuhui Ning; Chen Zhou; Shengyang Yang; Jie Zheng
Journal:  Angew Chem Int Ed Engl       Date:  2013-10-09       Impact factor: 15.336

Review 3.  Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.

Authors:  Nadezda Apostolova; Victor M Victor
Journal:  Antioxid Redox Signal       Date:  2015-03-10       Impact factor: 8.401

Review 4.  Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.

Authors:  Lefkothea C Papadopoulou; Asterios S Tsiftsoglou
Journal:  Pharm Res       Date:  2011-08-27       Impact factor: 4.200

5.  Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Authors:  Yuning Zhang; Pontus Lundberg; Maren Diether; Christian Porsch; Caroline Janson; Nathaniel A Lynd; Cosimo Ducani; Michael Malkoch; Eva Malmström; Craig J Hawker; Andreas M Nyström
Journal:  J Mater Chem B       Date:  2015-03-28       Impact factor: 6.331

6.  OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma.

Authors:  Xiangxuan Zhao; Changhai Tian; William M Puszyk; Olorunseun O Ogunwobi; Mengde Cao; Ton Wang; Roniel Cabrera; David R Nelson; Chen Liu
Journal:  Lab Invest       Date:  2012-10-29       Impact factor: 5.662

7.  Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.

Authors:  Jinbin Liu; Mengxiao Yu; Chen Zhou; Shengyang Yang; Xuhui Ning; Jie Zheng
Journal:  J Am Chem Soc       Date:  2013-03-22       Impact factor: 15.419

8.  MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.

Authors:  Reju George Thomas; Myeong Ju Moon; Suchithra Poilil Surendran; Hyeong Ju Park; In-Kyu Park; Byeong-Il Lee; Yong Yeon Jeong
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

Review 9.  Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.

Authors:  Miao Ding; Erlong Zhang; Rong He; Xingyong Wang
Journal:  Cancer Sci       Date:  2013-09-23       Impact factor: 6.716

10.  Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.

Authors:  Wen-Qun Li; Jun-Yong Wu; Da-Xiong Xiang; Shi-Lin Luo; Xiong-Bin Hu; Tian-Tian Tang; Tao-Li Sun; Xin-Yi Liu
Journal:  Int J Nanomedicine       Date:  2019-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.